NEW YORK, March 27, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company with small molecule and synthetic biology approaches to new therapies for rare and difficult-to-treat cancers, announced today that data from four preclinical studies – three focused on metastatic breast cancer – will be presented at the 2012 American Association for Cancer Research (AACR) Annual Meeting, being held March 31 – April 4 in Chicago, IL.
